University of Pittsburgh
The University of Pittsburgh conducts over $620 million in sponsored research annually, and ranks 6th in National Institutes of Health awards. This research activity generates over 200 invention disclosures on an annual basis, which are evaluated by the Office of Technology Management (OTM) in conjunction with the University Technology Transfer Committee for technical merit, market potential and patentability. Over 50 licenses or option agreements are executed yearly and 60 companies have been spun out of the university from 1996 to 2006.
The Office of Technology Management actively seeks to license the University’s IP portfolio to existing companies and also plays a founder role in the formation of new companies around platform technologies. The OTM also assists outside companies in identifying research collaborators within the University and in negotiating sponsored research agreements for such collaborations. It is in this capacity that OTM serves as “the bridge between science and business” at the University of Pittsburgh.
Innovations (312):
- Synthesis and biological evaluation of selective small-molecule inhibitors for protein kinase D (22 FEB 10)
- Chemical synthesis and antitumor activity of FR901464 and its analogs (22 FEB 10)
- Method and device for actuating and sensing highly nonlinear solitary waves in surfaces, structures, and materials (14 JAN 10)
- Animal Acoustic Stimulus Generation and Startle Software (14 JAN 10)
- Normalization of Time Domain-Optical Coherence Tomography (TD-OCT) Retinal Nerve Fiber Layer Thickness Measurements (14 JAN 10)
- Palmarumycin-based inhibitors of thioredoxin for cancer treatment (06 JAN 10)
- Next Generation Mixed Metal Transition Metal Non-Oxide Supercapacitors (06 JAN 10)
- PROMIS Emotional Distress and Sleep-Wake Function Scales (05 JAN 10)
- Dissolvable Microneedle Arrays for Effective Transdermal Delivery (04 JAN 10)
- Method for treatment of drug-resistant HIV-1 (18 DEC 09)
Find more innovations
